People who have to deal with the burden of an incurable disease often hold out hope that there will be a cure before the disease takes their lives. Diseases such as ALS, multiple sclerosis, Alzheimer’s, Type 1 diabetes and many types of cancer as well as a host of other diseases may have treatments to alleviate symptoms but the disease still moves in often relentless and unpredictable ways.
Hoping for a cure borders on delusional thinking partly because of the time it takes to develop treatments and also because of the cost of any curative regimen. A recent news item about sickle cell anemia drives this point home all too clearly.
A few years ago Jennifer Doudna and Emmanuelle Charpentier received the Nobel prize for their work with the gene editing technology called CRISPR. CRISPR is an acronym for clustered regularly interspersed palindromic repeats. It is a process that allows scientists to change the structure of genes.